Introduction
285℃ over 7 minutes at 10℃/min, ramped to 300℃ for 10 minutes at 10℃/min, and finally 1 0 7 ramped a third time to 325℃ over 5 minutes at 5℃/min. The total run time was 53.5 minutes, 1 0 8 and the injection volume was 1µL from a 10µL syringe. The samples were analyzed by electron 1 0 9 impact ionization in positive ion mode with a mass range of 50-550m/z, with the source 1 1 0 temperature at 230℃ and the quadrupole at 150℃. Data analysis was performed using Agilent 1 1 1 ChemStation software, with ion scans searched against the NIST database for identification. 1 1 2 Chemicals commonly found in each category (counterfeit, CBD-containing, and medical-grade) 1 1 3 of e-cig cartridges, but not found in other categories were identified and classified into terpenes, 1 1 4 silicon compounds, pesticide constituents, flavor additives, cannabinoids, plasticizers/ 1 1 5 polycaprolactones (PCP)/drugs/manufacturing agents, humectants/oil/plant components, 1 1 6 vitamin and conjugates, and miscellaneous constituents (Table 1) . 1 1 7
Quantifying vapor phase chemical constituents 1 1 8
Aerosols from e-cig vaping cartridges were sampled in 1L vacuum bottles, and each cartridge 1 1 9 was sampled for 10 minutes with 10 puffs each. These samples were sent to ALS 1 2 0 Environmental, CA, for analysis. Vapor phase constituents, including VOC, were screened and 1 2 1 quantified by EPA method TO-15 and mass spectral library search for tentatively identified 1 2 2 compounds. Most abundant compounds were then classified into groups based on their use, 1 2 3 i.e., terpenes, manufacturing/pesticides, automotive, solvents, PCP/household, and 1 2 4 miscellaneous constituents (Table 2) . 1 2 5
Elemental analysis of cartridge liquids 1 2 6
To screen for elements liquid aliquots from CBD-containing and counterfeit/patient-provided 1 2 7 cartridges, ICP-MS analysis was performed. Total Quant KED analysis of elements used 1 2 8
NeXion 2000 ICP-MS with external standards (20 ppb) solution in 2% nitric acid of 50 elements, 1 2 9 adding helium gas at a rate of 4 mL/min. The solutions were pumped into a Meinhard nebulizer 1 3 0 cooled to 2°C. This generated an aerosol that was aspirated into the plasma torch, where 1 3 1 ionization occurs. The ion beam was then detected by the mass spectrometer. The most 1 3 2 abundant elements in the liquids, particularly metals, were then tabulated (Table 3) More than 500 chemicals were found in tested cartridges. Chemical constituents peculiarly 1 3 7 present in e-cig counterfeit patient-provided, CBD-containing, and medical-grade cartridges are 1 3 8 listed in Table 1 . The majority of the compounds in e-cig cartridges were terpenes and silicon 1 3 9 compounds. Chemicals unique to e-cig counterfeit patient-provided specific cartridges include 1 4 0 2,2-dimethoxybutane, tetramethyl silicate, decane, methyl esters, ethyl esters, siloxanes, and 1 4 1 acetates, including α -tocopherol/vitamin E acetate (VEA). Apart from the chemicals listed above, 1 4 2 e-cig counterfeit patient cartridges consisted of many terpenes and their acetates. Other 1 4 3 compounds present included benzophenone, glycerol tricaprylate and similar products, and 1 4 4 THC and its derivatives. 1 4 5
In most e-cig vaping CBD-containing cartridges, cannabidiol was present as opposed to THC. 1 4 6
Glycerin, siloxanes, and flavoring chemicals, such as ethyl vanillin and coumarin compounds, 1 4 7 were found in CBD-containing e-cig cartridges. 1 4 8
In e-cig medical-grade cartridges, acetyl chloride, vitamin A retinol-conjugated compounds, such 1 4 9 as retinol acetate, rather than VEA, were present. 1 5 0
Vapor-phase constituents in counterfeit e-cig cartridges 1 5 1
By screening for the vapor-phase constituents in counterfeit patient cartridges, we identified and 1 5 2 quantified approximately 100 chemicals with concentrations ranging from 360,000 µg/m 3 to 169 1 5 3 µg/m 3 ( Table 2) . Predominantly these vapor-phase constituents were 1 5 4 manufacturing/pesticides/automotive/industrial active and inert agents and solvents. 1 5 5
Metal constituents in e-liquids 1 5 6
Elemental analysis of the e-liquids from THC-containing counterfeit patient-provided cartridges 1 5 7 was performed. Elements are presented in descending order, based on concentration found in 1 5 8 the liquids (Table 3 ). In counterfeit patient-cartridges, the most abundant elements included Si, 1 5 9
Cu, Ni, and Pb. These metal concentrations were highly variable between cartridges, though the 1 6 0 concentrations reached as high as 600 ppm. 1 6 1 Discussion 1 6 2
In this study, we investigated the chemical constituents commonly found in e-cig vaping patient-1 6 3 provided counterfeit cartridges, CBD-cartridges, and medical cartridges. We determined the key constituents in counterfeit patient, CBD, and medical-grade e-cig vaping 1 7 2 cartridges. We found several solvent chemicals, such as butane derivatives, i.e., 2,2 1 7 3 dimethoxybutane and n-butane, in both liquid and vapor phases of counterfeit e-cig cartridges. 1 7 4 This is likely a result of "dabbing" with butane hash oil. Dabbing an extraction procedure 1 7 5 commonly practiced in making illicit street cartridges as shown to improve total THC-recovery 1 7 6 and lung availability by greater than 70%, which is unachievable by smoking cannabis alone 1 7 7 (Hadener et al. 2019 were also higher measured as particulate matter (diameter 1.0, 2.5, and 10 μm) in counterfeit 1 8 9 patient cartridges vs MCT, mineral oil, and VEA, by Dustrack II 8530 instrument. Interactions 1 9 0 between these hydrocarbons, particulates and other organic oils, such as mineral oil, MCT oil, 1 9 1 and coconut oil, may promote or delay the absorption and metabolism of these compounds 1 9 2 (Gerarde 1959). However, given the nature of the disease manifestation of the reported cases 1 9 3 of EVALI with neutrophil and eosinophil infiltration in the BALF, and their successful treatment 1 9 4 with steroids, most of the cases may have been chemical-induced pneumonitis (Henry et al. In our chemical analysis, many conjugates and derivatives of silicon, such as silicates, silanes, 1 9 7 and siloxanes, were identified only in e-cig counterfeit cartridges. Moreover, we also found large 1 9 8 amounts of silica during elemental screening. These compounds, such as tetramethyl silicates, 1 9 9 can form secondary products, such as silicon dioxide (SiO 2 ) and methanol, which are highly 2 0 0 toxic. Inhalation of silicon compounds is known to cause acute lung injury with pulmonary 2 0 1 edema and lesions (NIOSH 2013).
0 2
It is believed that various hydrocarbons and reactive aldehydes are formed when e-liquids are 2 0 3 heated to high temperatures around 500 o F. All these cartridges, including CBD containing 2 0 4 cartridges, are used at the common voltages (e.g. 3.5V to 5.5 V) using a specific device (Chand 2 0 5 et al. 2019). These conditions were used to generate aerosols for the detection of chemical 2 0 6 constituents. Among the vapor-phase constituents, we found numerous known respiratory and 2 0 7 cardiac toxicants specifically in e-cig counterfeit cartridges that are listed as harmful or 2 0 8 potentially harmful constituents in tobacco products and tobacco smoke (HPHC) by the FDA. 2 0 9
These compounds found in e-cig counterfeit cartridges include isoprene, acetaldehyde, 2 1 0 ethylbenzene, toluene, acrolein, naphthalene, 1,3-butadiene, benzene, and vinyl chloride (FDA 2 1 1 2012).
1 2
Even though we detected VEA, we did not see VEA in all patient-provided counterfeit/street 2 1 3 cartridges, only some cartridges contained VEA. Interestingly, medical-grade cartridges 2 1 4 (formulation in coconut oil) contained retinol (vitamin A) acetate rather than VEA. Though there 2 1 5 were still harmful chemicals, such as acetyl chloride, benzene, aflatoxin b1 identified in medical-2 1 6 grade cartridges, the number of contaminants detected in these cartridges were fewer 2 1 7 compared to e-cig counterfeit patient-provided cartridges. 2 1 8
In counterfeit patient cartridges, we also found a common constituent in nasal sprays, 2 1 9 oxymetazoline (decongestant), an α 1 adrenergic receptor agonist. Common pesticide/insecticide 2 2 0 ingredients, such as naphthalene and hexadecanoic, methyl ester were also detected in liquid 2 2 1 and vapor phases of these e-cig counterfeit /patient cartridges. Exposure to very low levels of 2 2 2 naphthalene, in both young and older mice, has been shown to induce acute cytotoxicity and 2 2 3 injury to airway bronchiolar epithelial club cells (Carratt et al. 2019 ).
4
In the vapor-phase of e-cig counterfeit street cartridges, we detected many respiratory 2 2 5 depressants and paralytic agents, such as 4-methyl-2 pentene, acetaldehyde, ethylbenzene, 2 2 6 xylenes, and 1,3 pentadiene. Inhalation of these agents is likely the cause of symptoms, such 2 2 7 1 0 as dyspnea and chest tightness (common symptoms among EVALI patients). Inhalation of 2 2 8 compounds, such as acetone and trans -1,2, dichloroethane, and vinyl chloride, can cause 2 2 9 drowsiness, which is another common symptom among EVALI patients. Among the vapor 2 3 0 phase chemicals, inhalation of alkanes, such as n-butane and n-octane, causes acute lung 2 3 1 toxicity. Moreover, exposure to toxicants such as methyl vinyl ketone and allyl chloride is highly 2 3 2 toxic and causes emphysema, edema, and even vision impairment. 2 3 3
Chemical constituents in counterfeit cartridges, e.g., 1,3-butadiene, can self-polymerize and 2 3 4 form peroxides upon exposure to oxygen. These chemicals may react with other compounds 2 3 5 and further be catalyzed into forming secondary products (Levin et al. 2004) . Inhaled 2 3 6 xenobiotics undergo metabolism via phase I (CYP450/monooxygenase) and phase II 2 3 7 (transferases) forming metabolites and detoxification/elimination products. During these 2 3 8 processes, toxic metabolites may be formed. For example 1,3-butadiene has possible 2 3 9
intermediates that are DNA reactive metabolites, such as butadiene monoepoxide and 2 4 0 butadiene diepoxide (Dahl and Gerde 1994) . Aside from the detected e-liquid chemical 2 4 1 constituents, the lipid derivatives from the 'endogenous' source, such as the epithelial lining fluid 2 4 2 (ELF) and/or lung surfactants by interacting with exogenous hydrocarbons with phospholipids 2 4 3 and surfactants of the ELF, may also occur. This may be associated with the inflammatory 2 4 4 responses using these counterfeit cartridges seen in the lungs of patients with EVALI (Chand et 2 4 5 al. 2019). It remains to be seen whether the identified chemicals have any role for pathological 2 4 6 changes in the lung, such as centrilobular ground-glass nodules and ground-glass opacities with 2 4 7 subpleural sparing, as seen in patients with EVALI. 2 4 8
One of the limitations of this study includes the qualitative nature of the found 2 4 9 constituents/toxicants in cartridge liquids as the GC-MS method established for this study was 2 5 0 for preliminary screening to determine the presence of all constituents. It is possible that the 2 5 1 other States may have different counterfeit cartridges involved in EVALI, which need to 2 5 2 3 8 2 3 8 3 Tables  3  8  4  Table 1 : Commonly present constituents in counterfeit, CBD, and medical-grade e-cig 3 8 5 vaping counterfeit cartridges. 3 8 6 1,1a,1b,4,4a,5,7a,7b,8,9decahydro-4a ,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5oxo-9aH-cycloprop β -Myrcene D-Limonene Cyclohexene, 1-methyl-4-(1methylethylidene)-1,6-Octadien-3-ol, 3,7-dimethyl-3-Cyclohexene-1-methanol, α ,α4trimethyl-Caryophyllene
